Regenxbio Inc (RGNX)
16.87
+0.04
(+0.24%)
USD |
NASDAQ |
May 06, 16:00
16.88
0.00 (0.00%)
After-Hours: 20:00
Regenxbio Total Return Level: 16.87 for May 6, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 06, 2024 | 16.87 |
May 03, 2024 | 16.83 |
May 02, 2024 | 16.64 |
May 01, 2024 | 16.20 |
April 30, 2024 | 15.35 |
April 29, 2024 | 16.05 |
April 26, 2024 | 16.19 |
April 25, 2024 | 16.06 |
April 24, 2024 | 16.04 |
April 23, 2024 | 15.90 |
April 22, 2024 | 15.64 |
April 19, 2024 | 15.69 |
April 18, 2024 | 16.11 |
April 17, 2024 | 17.03 |
April 16, 2024 | 17.50 |
April 15, 2024 | 18.02 |
April 12, 2024 | 18.09 |
April 11, 2024 | 19.02 |
April 10, 2024 | 18.85 |
April 09, 2024 | 19.01 |
April 08, 2024 | 19.19 |
April 05, 2024 | 19.17 |
April 04, 2024 | 19.15 |
April 03, 2024 | 20.25 |
April 02, 2024 | 20.29 |
Date | Value |
---|---|
April 01, 2024 | 21.53 |
March 28, 2024 | 21.07 |
March 27, 2024 | 22.18 |
March 26, 2024 | 21.67 |
March 25, 2024 | 21.59 |
March 22, 2024 | 21.78 |
March 21, 2024 | 22.50 |
March 20, 2024 | 22.51 |
March 19, 2024 | 22.39 |
March 18, 2024 | 22.33 |
March 15, 2024 | 22.19 |
March 14, 2024 | 21.85 |
March 13, 2024 | 22.47 |
March 12, 2024 | 21.98 |
March 11, 2024 | 22.85 |
March 08, 2024 | 22.75 |
March 07, 2024 | 23.23 |
March 06, 2024 | 24.00 |
March 05, 2024 | 24.61 |
March 04, 2024 | 21.36 |
March 01, 2024 | 21.19 |
February 29, 2024 | 17.44 |
February 28, 2024 | 19.90 |
February 27, 2024 | 20.02 |
February 26, 2024 | 18.34 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
12.17
Minimum
Jan 30 2024
54.20
Maximum
Feb 13 2020
30.55
Average
31.20
Median
Aug 26 2021
Total Return Level Benchmarks
Sarepta Therapeutics Inc | 135.04 |
Amgen Inc | 416.44 |
Gilead Sciences Inc | 89.13 |
AbbVie Inc | 260.04 |
Bristol-Myers Squibb Co | 175.66 |